tiprankstipranks
Blurbs

Analysts Offer Insights on Healthcare Companies: Acadia Healthcare (ACHC), Alkermes (ALKS) and Hologic (HOLX)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Acadia Healthcare (ACHCResearch Report), Alkermes (ALKSResearch Report) and Hologic (HOLXResearch Report).

Acadia Healthcare (ACHC)

SVB Securities analyst Whit Mayo reiterated a Buy rating on Acadia Healthcare on July 27. The company’s shares closed last Thursday at $81.68.

According to TipRanks.com, Mayo is a 5-star analyst with an average return of 9.2% and a 57.4% success rate. Mayo covers the Healthcare sector, focusing on stocks such as Airsculpt Technologies, Inc., Alignment Healthcare, and Privia Health Group.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Acadia Healthcare with a $81.67 average price target, implying a -0.1% downside from current levels. In a report released yesterday, UBS also maintained a Buy rating on the stock with a $90.00 price target.

See today’s best-performing stocks on TipRanks >>

Alkermes (ALKS)

In a report issued on July 27, Marc Goodman from SVB Securities maintained a Hold rating on Alkermes, with a price target of $27.00. The company’s shares closed last Thursday at $26.55.

According to TipRanks.com, Goodman is a 2-star analyst with an average return of 0.2% and a 47.6% success rate. Goodman covers the Healthcare sector, focusing on stocks such as Biohaven Pharmaceutical Holding Co, Opthea Limited Sponsored ADR, and Amylyx Pharmaceuticals Inc.

Currently, the analyst consensus on Alkermes is a Hold with an average price target of $30.25, which is an 8.5% upside from current levels. In a report issued on July 27, Stifel Nicolaus also maintained a Hold rating on the stock with a $28.00 price target.

Hologic (HOLX)

In a report issued on July 27, Puneet Souda from SVB Securities maintained a Buy rating on Hologic, with a price target of $85.00. The company’s shares closed last Thursday at $70.78.

According to TipRanks.com, Souda is ranked 0 out of 5 stars with an average return of -8.7% and a 39.6% success rate. Souda covers the Healthcare sector, focusing on stocks such as AbCellera Biologics, Castle Biosciences, and Twist Bioscience.

Currently, the analyst consensus on Hologic is a Moderate Buy with an average price target of $76.60, representing an 8.8% upside. In a report released yesterday, Raymond James also maintained a Buy rating on the stock with a $80.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on ACHC:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More